)
)
Minerva Neurosciences Investor Relations Material
Latest events
Q1 2023
Minerva Neurosciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Minerva Neurosciences Inc
Access all reports
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. The company is developing brexanolone (MNRX), which targets all three types of glucocorticoid receptors to treat postpartum depression and infantile spasms in children. It also focuses on the research and development of a pipeline of compounds that modulate GABA receptors or downstream pathways and programs targeting other neurotransmitter systems. Minerva Neurosciences was founded in 2009 and is based in Menlo Park, California.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
NERV
Country
🇺🇸 United States